106 related articles for article (PubMed ID: 8151103)
1. Effects of reserpine administration in two models of portal hypertension in rats.
Lin HC; Yu PC; Lee SD; Tsai YT; Kuo JS; Yang MC
J Hepatol; 1993 Nov; 19(3):413-7. PubMed ID: 8151103
[TBL] [Abstract][Full Text] [Related]
2. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
Ohsuga M; Cailmail S; Lebrec D
J Hepatol; 1993 Feb; 17(2):236-40. PubMed ID: 8095275
[TBL] [Abstract][Full Text] [Related]
5. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
Braillon A; Cailmail S; Gaudin C; Lebrec D
J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term administration of octreotide in portal vein-stenosed rats.
Lin HC; Yang MC; Hou MC; Li SM; Huang YT; Yu PC; Tsai YT; Lee SD
Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
[TBL] [Abstract][Full Text] [Related]
8. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
Moreau R; Cailmail S; Lebrec D
Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
[TBL] [Abstract][Full Text] [Related]
9. Persistence of a hyperdynamic circulation in cirrhotic rats following removal of the sympathetic nervous system.
Abergel A; Braillon A; Gaudin C; Kleber G; Lebrec D
Gastroenterology; 1992 Feb; 102(2):656-60. PubMed ID: 1732135
[TBL] [Abstract][Full Text] [Related]
10. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
[TBL] [Abstract][Full Text] [Related]
11. Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension.
Cerini R; Lee SS; Hadengue A; Koshy A; Girod C; Lebrec D
Gastroenterology; 1988 Mar; 94(3):703-8. PubMed ID: 2892752
[TBL] [Abstract][Full Text] [Related]
12. Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats.
Lin HC; Soubrane O; Cailmail S; Lebrec D
J Hepatol; 1991 Sep; 13(2):213-9. PubMed ID: 1744426
[TBL] [Abstract][Full Text] [Related]
13. The hemodynamic effects of AT-112, an analog of ketanserin, in portal hypertensive rats.
Lin HC; Yang MC; Huang YT; Yu PC; Hou MC; Hong CY; Lee SD
Pharmacology; 1997 Jan; 54(1):16-23. PubMed ID: 9065957
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.
Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D
Eur J Pharmacol; 1996 Sep; 312(1):63-8. PubMed ID: 8891579
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Moreau R; Cailmail S; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
[TBL] [Abstract][Full Text] [Related]
17. Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats.
Nagasawa M; Kawasaki T; Yoshimi T
J Gastroenterol; 1996 Jun; 31(3):366-72. PubMed ID: 8726828
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
19. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Chen CF; Hong CY
J Gastroenterol Hepatol; 1997 Aug; 12(8):585-9. PubMed ID: 9304511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
